Abstract
Wastewater-based epidemiology has emerged as a powerful complement to clinical surveillance for monitoring infectious disease dynamics. However, most existing approaches either treat wastewater sites in isolation, overlooking spatial dependencies, and often fail to account for variability in data quality, limiting their ability to generate reliable predictions of healthcare demand. Here we present a spatial Bayesian renewal framework that integrates wastewater surveillance with mobility-informed spatial interactions while incorporating reliability-weighted wastewater signals. We apply the framework to three major respiratory pathogens, i.e., SARS-CoV-2, influenza, and respiratory syncytial virus (RSV), using wastewater and hospital data from counties in South Carolina. Across rolling four-week forecasts, the spatial framework consistently outperforms non-spatial approaches and remains robust even in counties lacking direct wastewater or hospitalization observations. Importantly, we show that county-level forecasts can be translated into facility-level predictions, enabling localized assessment of healthcare demand. These forecasts provide actionable early-warning signals to support hospital capacity planning, staffing decisions, and resource allocation. Together, this work establishes a scalable digital surveillance framework that integrates heterogeneous data sources for enabling more reliable infectious disease forecasting and supporting public health decision-making in underserved and data-limited settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project has been funded by the Center for Forecasting and Outbreak Analytics of the Centers for Disease Control and Prevention (CDC) under Award no. NU38FT000011 and the National Library of Medicine of the National Institutes of Health (NIH) under Award no. R01LM014193. The content and decision to publish is solely based on the authors of this study and does not necessarily represent the official views of the CDC or NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data "county-level and facility-level hospital admission data for respiratory illnesses" used in our study were aggregated/summary data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The authors do not have permission to share data.
